CIBC Asset Management Inc Grows Stake in Revvity Inc. $RVTY

CIBC Asset Management Inc grew its position in Revvity Inc. (NYSE:RVTY) by 49.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,249 shares of the company’s stock after purchasing an additional 8,344 shares during the quarter. CIBC Asset Management Inc’s holdings in Revvity were worth $2,443,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. CYBER HORNET ETFs LLC acquired a new stake in shares of Revvity during the second quarter worth $32,000. Cromwell Holdings LLC lifted its stake in shares of Revvity by 141.4% during the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after buying an additional 198 shares during the period. MUFG Securities EMEA plc acquired a new stake in shares of Revvity during the second quarter worth $34,000. Headlands Technologies LLC acquired a new stake in shares of Revvity during the second quarter worth $49,000. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Revvity by 56.8% during the third quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock worth $58,000 after buying an additional 250 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Stock Up 0.1%

Shares of RVTY opened at $98.46 on Monday. Revvity Inc. has a 52 week low of $81.22 and a 52 week high of $118.30. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $10.98 billion, a price-to-earnings ratio of 47.11, a PEG ratio of 2.15 and a beta of 1.11. The stock’s 50-day moving average price is $93.40 and its 200-day moving average price is $97.53.

Revvity (NYSE:RVTY) last issued its earnings results on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The firm had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. During the same quarter in the prior year, the business earned $1.01 earnings per share. The company’s revenue was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, sell-side analysts predict that Revvity Inc. will post 5.25 EPS for the current year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s dividend payout ratio is presently 13.40%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on RVTY shares. TD Cowen lifted their price objective on shares of Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Weiss Ratings downgraded shares of Revvity from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, May 13th. Barclays lifted their price objective on shares of Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. lowered their price objective on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Finally, Robert W. Baird set a $117.00 target price on shares of Revvity in a research report on Wednesday, May 6th. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Revvity has a consensus rating of “Hold” and an average price target of $107.73.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.